Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1998 Jul 21;9515:8443-8. doi: 10.1073/pnas.95.15.8443.
Show Gene links
Show Anatomy links
A model for MRI contrast enhancement using T1 agents.
Ahrens ET
,
Rothbächer U
,
Jacobs RE
,
Fraser SE
.
???displayArticle.abstract???
Contrast in MRI relies on differences in the local environment of water and is often enhanced by using contrast agents. We present a simple model for evaluating the minimal contrast agent concentration required to produce "satisfactory" contrast enhancement in magnetic resonance images. Previous strategies have been based largely on empirical results for specific systems. The present tissue contrast model (TCM) can be applied to "conventional," targeted, or biochemically responsive agents. The model results are formulated so that only a small number of parameters are required to analyze a given scenario. The TCM is a particularly useful tool in the development of new classes of magnetic resonance contrast media. These agents will have the ability to target specific cells or tissue, and perhaps be able to report on their physiological status. As an example of the applicability of the TCM, we test it against in vivo magnetic resonance microscopy results in frog embryos that have focal cell populations labeled with contrast agent by using calibrated single-cell microinjection techniques.
Brasch,
Rationale and applications for macromolecular Gd-based contrast agents.
1991, Pubmed
Brasch,
Rationale and applications for macromolecular Gd-based contrast agents.
1991,
Pubmed
Donahue,
Water diffusion and exchange as they influence contrast enhancement.
1997,
Pubmed
Donahue,
Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.
1994,
Pubmed
Edelstein,
Signal, noise, and contrast in nuclear magnetic resonance (NMR) imaging.
1983,
Pubmed
Greif,
Pulse sequence optimization for MR imaging using a paramagnetic hepatobiliary contrast agent.
1985,
Pubmed
Harika,
MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.
1995,
Pubmed
Hendrick,
Optimizing tissue contrast in magnetic resonance imaging.
1984,
Pubmed
Jacobs,
Magnetic resonance microscopy of embryonic cell lineages and movements.
1994,
Pubmed
,
Xenbase
Kayyem,
Receptor-targeted co-transport of DNA and magnetic resonance contrast agents.
1995,
Pubmed
Kellar,
Relaxation of solvent protons by solute Gd3+-chelates revisited.
1997,
Pubmed
Lauffer,
Targeted relaxation enhancement agents for MRI.
1991,
Pubmed
Lin,
Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function.
1997,
Pubmed
Nelson,
Selection of pulse sequences producing maximum tissue contrast in magnetic resonance imaging.
1984,
Pubmed
Perman,
Contrast manipulation in NMR imaging.
1984,
Pubmed
Roberts,
Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations.
1997,
Pubmed
Unger,
Magnetic resonance imaging using gadolinium labeled monoclonal antibody.
1985,
Pubmed
Wehrli,
The dependence of nuclear magnetic resonance (NMR) image contrast on intrinsic and pulse sequence timing parameters.
1984,
Pubmed
Weinmann,
A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI.
1991,
Pubmed